Pages that link to "Q36174832"

The following pages link to Next-Generation Sequencing to Guide Clinical Trials (Q36174832):

Displaying 17 items.

• Approaches to modernize the combination drug development paradigm (Q28072074) (← links)
• Data resources for the identification and interpretation of actionable mutations by clinicians. (Q36317783) (← links)
• Biomarker in Colorectal Cancer. (Q37114675) (← links)
• Perspective on Precision Medicine in Oncology (Q38717142) (← links)
• Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment (Q38838757) (← links)
• Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science (Q38996431) (← links)
• Advancing Clinical Trials to Streamline Drug Development (Q46111530) (← links)
• Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues. (Q47556879) (← links)
• Tumor molecular profiling of NSCLC patients using next generation sequencing. (Q47710730) (← links)
• Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer (Q49728493) (← links)
• The clinical impact of using complex molecular profiling strategies in routine oncology practice. (Q55009579) (← links)
• The growing role of precision and personalized medicine for cancer treatment (Q61449409) (← links)
• Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma (Q90077233) (← links)
• Database of evidence for precision oncology portal (Q90391867) (← links)
• The pathogenicity of novel GUCY2D mutations in Leber congenital amaurosis 1 assessed by HPLC-MS/MS (Q91630174) (← links)
• The Italian-Canine Cancer Biobank: Our 10-year challenge (Q92141289) (← links)
• Emerging Challenges and Opportunities in Infectious Disease Epidemiology (Q92403504) (← links)